New Marker for BRCA1 Gene in Breast Cancer
Author Information
Author(s): Catteau A, Xu C-F, Brown M A, Hodgson S, Greenman J, Mathew C G, Dunning A M, Solomon E
Primary Institution: Division of Medical and Molecular Genetics, UMDS
Hypothesis
Could regulatory mutations in the BRCA1 gene account for reduced expression in sporadic breast cancer?
Conclusion
The study found that deletions in the BRCA1 promoter region are rare in familial breast cancer and that mutations in this region are unlikely to explain decreased BRCA1 expression in sporadic cases.
Supporting Evidence
- No mutations were detected in the promoter region of BRCA1 in 20 patients.
- A new C-to-G polymorphism was identified with a G allele frequency of 0.34.
- Linkage disequilibrium was found between the new polymorphism and another known polymorphism.
- 214 familial breast cancer cases were analyzed using the new marker.
- 88 out of 214 cases were heterozygous for the promoter polymorphism.
- One hemizygous case reflecting a promoter deletion was identified.
Takeaway
Researchers looked for changes in a gene related to breast cancer and found a new marker that helps identify certain genetic deletions, but these deletions are not common.
Methodology
Sequencing of the BRCA1 promoter region in 20 patients with sporadic breast cancer and analysis of 214 familial breast cancer cases.
Limitations
The study focused only on specific polymorphisms and may not account for all genetic factors in breast cancer.
Participant Demographics
20 patients with sporadic breast cancer and 214 cases with familial breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website